NGSX Financials 07/16/2014 10:54:47 NeurogesX, In
Post# of 4
Posted On: 07/16/2014 11:54:43 AM
NGSX Financials 07/16/2014 10:54:47
NeurogesX, Inc.
Period Ending Dec 31, 2011 Dec 31, 2010
Total Revenue 11,503 8,266
Cost of Revenue 685 541
Gross Profit 10,818 7,725
Operating Expenses
Research and Development 13,566 11,151
Sales, General and Admin. 36,408 36,383
Non-Recurring Items - -
Other - -
Operating Income (39,156) (39,809)
Income From Continuing Operations
Add'l Income/Expense Items 16 706
Earnings Before Interest and Tax (39,140) (39,103)
Interest Expense 10,405 5,413
Earnings Before Tax (49,545) (44,516)
Income Tax - -
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations (49,545) (44,516)
Non Recurring Events
Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income (49,545) (44,516)
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders (49,545) (44,516)
NeurogesX, Inc.
Period Ending Dec 31, 2011 Dec 31, 2010
Total Revenue 11,503 8,266
Cost of Revenue 685 541
Gross Profit 10,818 7,725
Operating Expenses
Research and Development 13,566 11,151
Sales, General and Admin. 36,408 36,383
Non-Recurring Items - -
Other - -
Operating Income (39,156) (39,809)
Income From Continuing Operations
Add'l Income/Expense Items 16 706
Earnings Before Interest and Tax (39,140) (39,103)
Interest Expense 10,405 5,413
Earnings Before Tax (49,545) (44,516)
Income Tax - -
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations (49,545) (44,516)
Non Recurring Events
Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income (49,545) (44,516)
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders (49,545) (44,516)
(0)
(0)NeurogesX, Inc. (NGSX) Stock Research Links
Scroll down for more posts ▼